European markets opened higher Thursday as global markets are buoyed by trials of a potentially effective coronavirus treatment.
The pan-European Stoxx 600 climbed 0.6% at the start of trading, autos jumping 2.4% to lead gains while basic resources bucked the upward trend to edge 0.3% lower.
Investors in Europe will be reacting to news from the U.S. Wednesday regarding the use of Gilead Sciences’ antiviral drug remdesivir as a potential new treatment for Covid-19 patients.
Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a five-day dosage of remdesivir improved and more than half were discharged from the hospital within two weeks.
Source : CNBC